Special Issue "New Frontiers in Structural Heart Disease"
Deadline for manuscript submissions: 31 December 2021.
In recent years, the field of structural heart disease has experienced an immense evolution in diagnostic and treatment modalities, including transcatheter aortic valve implantation (TAVI), which has expanded in application from high-surgical-risk to low-risk patients and will be a disruptive technology in the management of aortic valve disease patients. Mitral clip has shown superb results for the mortality and rehospitalization of heart failure patients with mitral regurgitation and is currently also being studied in tricuspid regurgitation patients. The percutaneous closure of the left atrial appendage has been shown to reduce bleeding, and in patients at high risk of bleeding, patent foramen ovale closure has been shown to reduce recurrent strokes. These developments have enabled a further understanding of the disease process and improved diagnostic pathways such as the use of various imaging software and research into various conditions such as low-flow, low-gradient aortic stenosis. Further therapeutic solutions are in development for various structural heart disease conditions, while the diagnosis and therapy of these patients is continuously improving, allowing safer, more efficacious, less invasive and more personalized treatment options.
The current issue is aimed at presenting cutting-edge research and a review of recent developments in the various structural heart disorders.
Dr. Edward Koifman
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- structural heart disease
- aortic valve disease
- mitral valve disease
- tricuspid valve disease
- left atrial appendage closure
- patent foramen ovale
- atrial septal defect